Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Favipiravir vs Ribavirin for COVID-19
NCT04828564Phase 3Unknown
- Sponsor
- The Scientific and Technological Research Council of Turkey
- Start
- Apr 2021
- Primary completion
- Sep 2021
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of ribavirin in coronavirus disease 2019 (COVID-19), sponsored by The Scientific and Technological Research Council of Turkey. Status: unknown.
02
Drugs
ribavirin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04828564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04828564.